Skin-colonizing bacteria help fight tumors
In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.
DNA circles drive cancer development
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.
Stanford Medicine communications awards
Faculty and Office of Communications staff earn nine awards from the Association of American Medical Colleges.
Osteoarthritis linked to allergic inflammation
A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.
Bryan Myers dies at 86
The Stanford Medicine professor emeritus of nephrology was chief of the Division of Nephrology for nearly 20 years, training nephrologists who now practice around the world.
Stanford Medicine gives to the community
Stanford Medicine donated more than $950 million in funds and services during the 2022 fiscal year, focusing on access to health care, housing and nutrition.
Long-COVID clinical trials underway
Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.
New app detects mpox
Researchers were able to devise an app that can determine which skin lesions are caused by mpox with an accuracy of 90%.
Racing heart drives anxiety in mice
Using pulses of light to control heart rate, Stanford Medicine researchers investigate a long-standing mystery about how physical states influence emotions.
Cancer cells become cancer cure
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.